Brief: Spruce Biosciences Announces Pediatric Classic CAH Program Details During Virtual Research And Development Day
25/08/2021 14:17
Aug 25 (Reuters) - Spruce Biosciences Inc SPRB.O :
* SPRUCE BIOSCIENCES ANNOUNCES PEDIATRIC CLASSIC CAH PROGRAM
DETAILS DURING VIRTUAL RESEARCH AND DEVELOPMENT DAY
* SPRUCE BIOSCIENCES - PHASE 2 PROGRAM IN PEDIATRIC CLASSIC
CAH ON
TRACK TO INITIATE IN 2021 WITH DATA EXPECTED BY 1H 2023
* SPRUCE BIOSCIENCES INC - PHASE 3 REGISTRATIONAL PROGRAM IN
PEDIATRIC CLASSIC CAH EXPECTED TO INITIATE IN 2023
Source text for Eikon: ID:nBw3zHndda
Further company coverage: SPRB.O
(((Reuters.Briefs@thomsonreuters.com);))
Recent news on Spruce Biosciences
See all newsSpruce Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Spruce Biosciences Q2 net loss widens on higher expenses
Spruce Biosciences, Inc. expected to post a loss of $5.80 a share - Earnings Preview
Brief: Spruce Biosciences Appoints Adrian Quartel, M.D., Ffpm, As Chief Medical Officer
Brief: Spruce Biosciences Announces Data Presentation At The 18Th International MPS Symposium